-+ 0.00%
-+ 0.00%
-+ 0.00%
Tenon Medical Regains Nasdaq Compliance Relating To Maintaining Shareholders' Equity Minimum Of $2.5M
Share
Listen to the news

On July 17, 2026, the Company received a notice from Nasdaq that, based on the July 10 8-K (as defined below), the Company had regained compliance with the Stockholders' Equity Rule (as defined below). However, if the Company fails to evidence compliance upon filing its Quarterly Report on Form 10-Q for the period ending September 30, 2026, the Company may be subject to delisting, and any such delisting would be subject to appeal.

On July 10, 2026, the Company filed a Current Report on Form 8-K (the "July 10 8-K") that disclosed its belief that it satisfied Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Rule") as of such filing date due to the completion of its $4.2 million public offering of common stock and warrants on July 1, 2026.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending